Company Description

NexEos Bio is a clinical-stage biopharmaceutical company developing novel therapies and diagnostics targeting eosinophil-mediated diseases. We are a privately held therapeutics and diagnostics company dedicated to improving the detection, diagnosis, treatment and life-long management of patients living with chronic, eosinophil-related inflammatory diseases.